, in which nanoceria serves as a reducing agent rather than a catalyst. The chemical reduction pathways poison the active sites of nanoceria which serve to mimic SOD and thus deteriorate its SOD mimetic activity. The results provide guidance for the engineering of nanoceria for bio-antioxidant applications. In particular, the proposed catalytic model can be generalized for the screening and design of high-performance nanozymes based on semiconductor nanomaterials.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: